NeoBioMed Services, founded in May 2006, is a privately held partnership company having base in New Delhi, capital city of India. The company is led by a management team headed by its Chief Executive Officer Dr. Brij M. Gandhi (https://drbmgandhi.com/), a scientist and a technocrat with more than 52 years of experience; in clinical research sciences and services; policy and administration with Ministry of Science and Technology, Government of India; and post retirement positions as Advisor / Director / Consultant to a number of Universities, Institutions, Industries and Industry Organizations.
Service Provider: NeoBioMed Services is providing complete solutions for import and export of bulk drugs and related regulatory issues involving government dealings, securing registration of manufacturing plant, products and formulations, grant of test license, approvals of protocols for BE / CT and issues of final permissions for manufacturing & marketing. Services include segments for APIs, pharmaceuticals, biopharmaceuticals, medical devices including bioimplants, regenerative medicine and tissue engineering including stem cell research and application, designing GMP, GLP, containment facilities and other related commercial activities and businesses.
Consultants: NeoBioMed Services helps in securing partnership and linkages with leading institutions, hospitals, R&D establishments, individuals and industrial houses in India in developing any commercial relations adhering to international standards and norms and WHO-GMP. Consultancy and services are provided to support pharma / biopharma / medical device and In-vitro Diagnostic (IVD) companies for clinical and pre-clinical studies including interactions with concerned departments of the government, trade and industrial organizations. NeoBioMed also supports writing of grants for securing funding from public grants.